nodes	percent_of_prediction	percent_of_DWPC	metapath
Propericiazine—Nausea—Crizotinib—lung cancer	0.00258	0.00282	CcSEcCtD
Propericiazine—Jaundice—Irinotecan—lung cancer	0.00257	0.0028	CcSEcCtD
Propericiazine—Arrhythmia—Vinorelbine—lung cancer	0.00256	0.0028	CcSEcCtD
Propericiazine—Body temperature increased—Teniposide—lung cancer	0.00254	0.00277	CcSEcCtD
Propericiazine—Hypokalaemia—Paclitaxel—lung cancer	0.00254	0.00277	CcSEcCtD
Propericiazine—Vomiting—Pemetrexed—lung cancer	0.00252	0.00275	CcSEcCtD
Propericiazine—Vomiting—Gefitinib—lung cancer	0.00251	0.00274	CcSEcCtD
Propericiazine—Rash—Pemetrexed—lung cancer	0.0025	0.00273	CcSEcCtD
Propericiazine—Dermatitis—Pemetrexed—lung cancer	0.0025	0.00273	CcSEcCtD
Propericiazine—Rash—Gefitinib—lung cancer	0.00248	0.00271	CcSEcCtD
Propericiazine—Dermatitis—Gefitinib—lung cancer	0.00248	0.00271	CcSEcCtD
Propericiazine—Liver injury—Doxorubicin—lung cancer	0.00241	0.00264	CcSEcCtD
Propericiazine—Agranulocytosis—Gemcitabine—lung cancer	0.00239	0.00262	CcSEcCtD
Propericiazine—Sweating increased—Etoposide—lung cancer	0.00239	0.00261	CcSEcCtD
Propericiazine—Hypersensitivity—Teniposide—lung cancer	0.00237	0.00259	CcSEcCtD
Propericiazine—Infection—Topotecan—lung cancer	0.00237	0.00258	CcSEcCtD
Propericiazine—Oedema—Erlotinib—lung cancer	0.00236	0.00257	CcSEcCtD
Propericiazine—Nausea—Pemetrexed—lung cancer	0.00236	0.00257	CcSEcCtD
Propericiazine—Sweating increased—Paclitaxel—lung cancer	0.00235	0.00256	CcSEcCtD
Propericiazine—Pulmonary embolism—Methotrexate—lung cancer	0.00235	0.00256	CcSEcCtD
Propericiazine—Nausea—Gefitinib—lung cancer	0.00234	0.00256	CcSEcCtD
Propericiazine—Infection—Erlotinib—lung cancer	0.00234	0.00256	CcSEcCtD
Propericiazine—Amenorrhoea—Doxorubicin—lung cancer	0.00231	0.00253	CcSEcCtD
Propericiazine—Jaundice cholestatic—Doxorubicin—lung cancer	0.00231	0.00253	CcSEcCtD
Propericiazine—Hyperhidrosis—Topotecan—lung cancer	0.0023	0.00251	CcSEcCtD
Propericiazine—Angioedema—Vinorelbine—lung cancer	0.00228	0.00249	CcSEcCtD
Propericiazine—Pneumonia—Etoposide—lung cancer	0.0022	0.00241	CcSEcCtD
Propericiazine—Photosensitivity reaction—Paclitaxel—lung cancer	0.0022	0.0024	CcSEcCtD
Propericiazine—Diarrhoea—Teniposide—lung cancer	0.0022	0.0024	CcSEcCtD
Propericiazine—Cardiac disorder—Irinotecan—lung cancer	0.00219	0.0024	CcSEcCtD
Propericiazine—Weight increased—Paclitaxel—lung cancer	0.00219	0.00239	CcSEcCtD
Propericiazine—Hyperglycaemia—Paclitaxel—lung cancer	0.00217	0.00237	CcSEcCtD
Propericiazine—Dyskinesia—Doxorubicin—lung cancer	0.00216	0.00236	CcSEcCtD
Propericiazine—Pneumonia—Paclitaxel—lung cancer	0.00216	0.00236	CcSEcCtD
Propericiazine—Cardiac disorder—Gemcitabine—lung cancer	0.00214	0.00233	CcSEcCtD
Propericiazine—Jaundice—Etoposide—lung cancer	0.00214	0.00233	CcSEcCtD
Propericiazine—Insomnia—Erlotinib—lung cancer	0.00213	0.00233	CcSEcCtD
Propericiazine—Dyspnoea—Topotecan—lung cancer	0.00212	0.00232	CcSEcCtD
Propericiazine—Arrhythmia—Irinotecan—lung cancer	0.00211	0.00231	CcSEcCtD
Propericiazine—Dyspnoea—Erlotinib—lung cancer	0.0021	0.00229	CcSEcCtD
Propericiazine—Gynaecomastia—Methotrexate—lung cancer	0.0021	0.00229	CcSEcCtD
Propericiazine—Constipation—Vinblastine—lung cancer	0.0021	0.00229	CcSEcCtD
Propericiazine—Atrioventricular block—Doxorubicin—lung cancer	0.00209	0.00229	CcSEcCtD
Propericiazine—Arrhythmia—Gemcitabine—lung cancer	0.00206	0.00225	CcSEcCtD
Propericiazine—Agranulocytosis—Etoposide—lung cancer	0.00204	0.00223	CcSEcCtD
Propericiazine—Vomiting—Teniposide—lung cancer	0.00204	0.00223	CcSEcCtD
Propericiazine—Constipation—Topotecan—lung cancer	0.00204	0.00222	CcSEcCtD
Propericiazine—Ventricular tachycardia—Doxorubicin—lung cancer	0.00203	0.00222	CcSEcCtD
Propericiazine—Pulmonary embolism—Doxorubicin—lung cancer	0.00203	0.00222	CcSEcCtD
Propericiazine—Rash—Teniposide—lung cancer	0.00203	0.00221	CcSEcCtD
Propericiazine—Dermatitis—Teniposide—lung cancer	0.00202	0.00221	CcSEcCtD
Propericiazine—Infection—Vinorelbine—lung cancer	0.00202	0.00221	CcSEcCtD
Propericiazine—Constipation—Erlotinib—lung cancer	0.00201	0.0022	CcSEcCtD
Propericiazine—Clomipramine—GSTP1—lung cancer	0.002	0.141	CrCbGaD
Propericiazine—Cardiac disorder—Cisplatin—lung cancer	0.00199	0.00218	CcSEcCtD
Propericiazine—Tachycardia—Vinorelbine—lung cancer	0.00199	0.00217	CcSEcCtD
Propericiazine—Photosensitivity—Methotrexate—lung cancer	0.00194	0.00212	CcSEcCtD
Propericiazine—Arrhythmia—Cisplatin—lung cancer	0.00192	0.00209	CcSEcCtD
Propericiazine—Nausea—Teniposide—lung cancer	0.00191	0.00208	CcSEcCtD
Propericiazine—Hypotension—Vinorelbine—lung cancer	0.0019	0.00208	CcSEcCtD
Propericiazine—Body temperature increased—Topotecan—lung cancer	0.00188	0.00206	CcSEcCtD
Propericiazine—Body temperature increased—Erlotinib—lung cancer	0.00186	0.00203	CcSEcCtD
Propericiazine—Weight increased—Docetaxel—lung cancer	0.00186	0.00203	CcSEcCtD
Propericiazine—Pneumonia—Docetaxel—lung cancer	0.00183	0.002	CcSEcCtD
Propericiazine—Cardiac disorder—Etoposide—lung cancer	0.00183	0.00199	CcSEcCtD
Propericiazine—Dyspnoea—Vinorelbine—lung cancer	0.00182	0.00198	CcSEcCtD
Propericiazine—Hypersensitivity—Vinblastine—lung cancer	0.00181	0.00197	CcSEcCtD
Propericiazine—Cardiac disorder—Paclitaxel—lung cancer	0.00179	0.00195	CcSEcCtD
Propericiazine—Jaundice—Docetaxel—lung cancer	0.00177	0.00194	CcSEcCtD
Propericiazine—Vision blurred—Cisplatin—lung cancer	0.00176	0.00192	CcSEcCtD
Propericiazine—Hypersensitivity—Topotecan—lung cancer	0.00175	0.00192	CcSEcCtD
Propericiazine—Tremor—Cisplatin—lung cancer	0.00175	0.00191	CcSEcCtD
Propericiazine—Constipation—Vinorelbine—lung cancer	0.00174	0.0019	CcSEcCtD
Propericiazine—Arrhythmia—Paclitaxel—lung cancer	0.00172	0.00188	CcSEcCtD
Propericiazine—Agranulocytosis—Docetaxel—lung cancer	0.0017	0.00186	CcSEcCtD
Propericiazine—Confusional state—Irinotecan—lung cancer	0.00169	0.00185	CcSEcCtD
Propericiazine—Oedema—Irinotecan—lung cancer	0.00168	0.00183	CcSEcCtD
Propericiazine—Photosensitivity—Doxorubicin—lung cancer	0.00168	0.00183	CcSEcCtD
Propericiazine—Diarrhoea—Vinblastine—lung cancer	0.00168	0.00183	CcSEcCtD
Propericiazine—Infection—Irinotecan—lung cancer	0.00167	0.00182	CcSEcCtD
Propericiazine—Oedema—Gemcitabine—lung cancer	0.00164	0.00179	CcSEcCtD
Propericiazine—Diarrhoea—Topotecan—lung cancer	0.00163	0.00178	CcSEcCtD
Propericiazine—Infection—Gemcitabine—lung cancer	0.00163	0.00178	CcSEcCtD
Propericiazine—Hyperhidrosis—Irinotecan—lung cancer	0.00162	0.00177	CcSEcCtD
Propericiazine—Diarrhoea—Erlotinib—lung cancer	0.00161	0.00176	CcSEcCtD
Propericiazine—Body temperature increased—Vinorelbine—lung cancer	0.00161	0.00176	CcSEcCtD
Propericiazine—Vision blurred—Paclitaxel—lung cancer	0.00158	0.00173	CcSEcCtD
Propericiazine—Hyperhidrosis—Gemcitabine—lung cancer	0.00158	0.00173	CcSEcCtD
Propericiazine—Tremor—Paclitaxel—lung cancer	0.00157	0.00172	CcSEcCtD
Propericiazine—Hypotension—Irinotecan—lung cancer	0.00157	0.00171	CcSEcCtD
Propericiazine—Increased appetite—Doxorubicin—lung cancer	0.00157	0.00171	CcSEcCtD
Propericiazine—Vomiting—Vinblastine—lung cancer	0.00156	0.0017	CcSEcCtD
Propericiazine—Agitation—Paclitaxel—lung cancer	0.00154	0.00169	CcSEcCtD
Propericiazine—Angioedema—Paclitaxel—lung cancer	0.00153	0.00168	CcSEcCtD
Propericiazine—Hypotension—Gemcitabine—lung cancer	0.00153	0.00167	CcSEcCtD
Propericiazine—Oedema—Cisplatin—lung cancer	0.00153	0.00167	CcSEcCtD
Propericiazine—Insomnia—Irinotecan—lung cancer	0.00152	0.00166	CcSEcCtD
Propericiazine—Cardiac disorder—Docetaxel—lung cancer	0.00152	0.00166	CcSEcCtD
Propericiazine—Infection—Cisplatin—lung cancer	0.00152	0.00166	CcSEcCtD
Propericiazine—Vomiting—Topotecan—lung cancer	0.00151	0.00165	CcSEcCtD
Propericiazine—Rash—Topotecan—lung cancer	0.0015	0.00164	CcSEcCtD
Propericiazine—Hypersensitivity—Vinorelbine—lung cancer	0.0015	0.00164	CcSEcCtD
Propericiazine—Dermatitis—Topotecan—lung cancer	0.0015	0.00164	CcSEcCtD
Propericiazine—Vomiting—Erlotinib—lung cancer	0.0015	0.00164	CcSEcCtD
Propericiazine—Dyspnoea—Irinotecan—lung cancer	0.0015	0.00164	CcSEcCtD
Propericiazine—Somnolence—Irinotecan—lung cancer	0.00149	0.00163	CcSEcCtD
Propericiazine—Tachycardia—Cisplatin—lung cancer	0.00149	0.00163	CcSEcCtD
Propericiazine—Rash—Erlotinib—lung cancer	0.00149	0.00162	CcSEcCtD
Propericiazine—Dermatitis—Erlotinib—lung cancer	0.00148	0.00162	CcSEcCtD
Propericiazine—Insomnia—Gemcitabine—lung cancer	0.00148	0.00162	CcSEcCtD
Propericiazine—Hyperhidrosis—Cisplatin—lung cancer	0.00147	0.00161	CcSEcCtD
Propericiazine—Asthma—Methotrexate—lung cancer	0.00147	0.00161	CcSEcCtD
Propericiazine—Arrhythmia—Docetaxel—lung cancer	0.00146	0.00159	CcSEcCtD
Propericiazine—Dyspnoea—Gemcitabine—lung cancer	0.00146	0.00159	CcSEcCtD
Propericiazine—Eosinophilia—Methotrexate—lung cancer	0.00146	0.00159	CcSEcCtD
Propericiazine—Nausea—Vinblastine—lung cancer	0.00146	0.00159	CcSEcCtD
Propericiazine—Somnolence—Gemcitabine—lung cancer	0.00145	0.00159	CcSEcCtD
Propericiazine—Constipation—Irinotecan—lung cancer	0.00144	0.00157	CcSEcCtD
Propericiazine—Hypotension—Cisplatin—lung cancer	0.00143	0.00156	CcSEcCtD
Propericiazine—Nausea—Topotecan—lung cancer	0.00141	0.00154	CcSEcCtD
Propericiazine—Confusional state—Etoposide—lung cancer	0.00141	0.00154	CcSEcCtD
Propericiazine—Constipation—Gemcitabine—lung cancer	0.0014	0.00153	CcSEcCtD
Propericiazine—Nausea—Erlotinib—lung cancer	0.0014	0.00153	CcSEcCtD
Propericiazine—Dry mouth—Paclitaxel—lung cancer	0.0014	0.00153	CcSEcCtD
Propericiazine—Diarrhoea—Vinorelbine—lung cancer	0.00139	0.00152	CcSEcCtD
Propericiazine—Infection—Etoposide—lung cancer	0.00139	0.00152	CcSEcCtD
Propericiazine—Confusional state—Paclitaxel—lung cancer	0.00138	0.00151	CcSEcCtD
Propericiazine—Oedema—Paclitaxel—lung cancer	0.00137	0.0015	CcSEcCtD
Propericiazine—Tachycardia—Etoposide—lung cancer	0.00136	0.00149	CcSEcCtD
Propericiazine—Infection—Paclitaxel—lung cancer	0.00136	0.00149	CcSEcCtD
Propericiazine—Dyspnoea—Cisplatin—lung cancer	0.00136	0.00149	CcSEcCtD
Propericiazine—Erectile dysfunction—Methotrexate—lung cancer	0.00136	0.00148	CcSEcCtD
Propericiazine—Hyperhidrosis—Etoposide—lung cancer	0.00135	0.00148	CcSEcCtD
Propericiazine—Photosensitivity reaction—Methotrexate—lung cancer	0.00134	0.00147	CcSEcCtD
Propericiazine—Hypokalaemia—Doxorubicin—lung cancer	0.00134	0.00147	CcSEcCtD
Propericiazine—Tachycardia—Paclitaxel—lung cancer	0.00134	0.00146	CcSEcCtD
Propericiazine—Body temperature increased—Irinotecan—lung cancer	0.00133	0.00145	CcSEcCtD
Propericiazine—Hyperhidrosis—Paclitaxel—lung cancer	0.00132	0.00145	CcSEcCtD
Propericiazine—Pneumonia—Methotrexate—lung cancer	0.00132	0.00144	CcSEcCtD
Propericiazine—Drowsiness—Methotrexate—lung cancer	0.00131	0.00143	CcSEcCtD
Propericiazine—Hypotension—Etoposide—lung cancer	0.00131	0.00143	CcSEcCtD
Propericiazine—Vomiting—Vinorelbine—lung cancer	0.00129	0.00141	CcSEcCtD
Propericiazine—Body temperature increased—Gemcitabine—lung cancer	0.00129	0.00141	CcSEcCtD
Propericiazine—Rash—Vinorelbine—lung cancer	0.00128	0.0014	CcSEcCtD
Propericiazine—Dermatitis—Vinorelbine—lung cancer	0.00128	0.0014	CcSEcCtD
Propericiazine—Hypotension—Paclitaxel—lung cancer	0.00128	0.0014	CcSEcCtD
Propericiazine—Asthma—Doxorubicin—lung cancer	0.00127	0.00139	CcSEcCtD
Propericiazine—Eosinophilia—Doxorubicin—lung cancer	0.00126	0.00138	CcSEcCtD
Propericiazine—Dyspnoea—Etoposide—lung cancer	0.00125	0.00136	CcSEcCtD
Propericiazine—Somnolence—Etoposide—lung cancer	0.00124	0.00136	CcSEcCtD
Propericiazine—Insomnia—Paclitaxel—lung cancer	0.00124	0.00135	CcSEcCtD
Propericiazine—Hypersensitivity—Irinotecan—lung cancer	0.00124	0.00135	CcSEcCtD
Propericiazine—Agranulocytosis—Methotrexate—lung cancer	0.00122	0.00134	CcSEcCtD
Propericiazine—Dyspnoea—Paclitaxel—lung cancer	0.00122	0.00133	CcSEcCtD
Propericiazine—Somnolence—Paclitaxel—lung cancer	0.00122	0.00133	CcSEcCtD
Propericiazine—Nausea—Vinorelbine—lung cancer	0.00121	0.00132	CcSEcCtD
Propericiazine—Body temperature increased—Cisplatin—lung cancer	0.00121	0.00132	CcSEcCtD
Propericiazine—Constipation—Etoposide—lung cancer	0.00119	0.00131	CcSEcCtD
Propericiazine—Dry mouth—Docetaxel—lung cancer	0.00118	0.00129	CcSEcCtD
Propericiazine—Constipation—Paclitaxel—lung cancer	0.00117	0.00128	CcSEcCtD
Propericiazine—Confusional state—Docetaxel—lung cancer	0.00117	0.00128	CcSEcCtD
Propericiazine—Photosensitivity reaction—Doxorubicin—lung cancer	0.00116	0.00127	CcSEcCtD
Propericiazine—Oedema—Docetaxel—lung cancer	0.00116	0.00127	CcSEcCtD
Propericiazine—Weight increased—Doxorubicin—lung cancer	0.00116	0.00127	CcSEcCtD
Propericiazine—Infection—Docetaxel—lung cancer	0.00115	0.00126	CcSEcCtD
Propericiazine—Hyperglycaemia—Doxorubicin—lung cancer	0.00115	0.00126	CcSEcCtD
Propericiazine—Diarrhoea—Irinotecan—lung cancer	0.00115	0.00126	CcSEcCtD
Propericiazine—Pneumonia—Doxorubicin—lung cancer	0.00114	0.00125	CcSEcCtD
Propericiazine—Drowsiness—Doxorubicin—lung cancer	0.00114	0.00124	CcSEcCtD
Propericiazine—Tachycardia—Docetaxel—lung cancer	0.00113	0.00124	CcSEcCtD
Propericiazine—Hypersensitivity—Cisplatin—lung cancer	0.00112	0.00123	CcSEcCtD
Propericiazine—Diarrhoea—Gemcitabine—lung cancer	0.00112	0.00122	CcSEcCtD
Propericiazine—Fluphenazine—CYP2E1—lung cancer	0.00112	0.0792	CrCbGaD
Propericiazine—Jaundice—Doxorubicin—lung cancer	0.00111	0.00121	CcSEcCtD
Propericiazine—Body temperature increased—Etoposide—lung cancer	0.0011	0.00121	CcSEcCtD
Propericiazine—Cardiac disorder—Methotrexate—lung cancer	0.00109	0.00119	CcSEcCtD
Propericiazine—Hypotension—Docetaxel—lung cancer	0.00108	0.00119	CcSEcCtD
Propericiazine—Body temperature increased—Paclitaxel—lung cancer	0.00108	0.00118	CcSEcCtD
Propericiazine—Vomiting—Irinotecan—lung cancer	0.00107	0.00117	CcSEcCtD
Propericiazine—Agranulocytosis—Doxorubicin—lung cancer	0.00106	0.00116	CcSEcCtD
Propericiazine—Rash—Irinotecan—lung cancer	0.00106	0.00116	CcSEcCtD
Propericiazine—Dermatitis—Irinotecan—lung cancer	0.00106	0.00116	CcSEcCtD
Propericiazine—Insomnia—Docetaxel—lung cancer	0.00105	0.00115	CcSEcCtD
Propericiazine—Diarrhoea—Cisplatin—lung cancer	0.00104	0.00114	CcSEcCtD
Propericiazine—Vomiting—Gemcitabine—lung cancer	0.00104	0.00114	CcSEcCtD
Propericiazine—Dyspnoea—Docetaxel—lung cancer	0.00104	0.00113	CcSEcCtD
Propericiazine—Somnolence—Docetaxel—lung cancer	0.00103	0.00113	CcSEcCtD
Propericiazine—Rash—Gemcitabine—lung cancer	0.00103	0.00113	CcSEcCtD
Propericiazine—Dermatitis—Gemcitabine—lung cancer	0.00103	0.00113	CcSEcCtD
Propericiazine—Hypersensitivity—Etoposide—lung cancer	0.00103	0.00112	CcSEcCtD
Propericiazine—Hypersensitivity—Paclitaxel—lung cancer	0.00101	0.0011	CcSEcCtD
Propericiazine—Nausea—Irinotecan—lung cancer	0.000998	0.00109	CcSEcCtD
Propericiazine—Constipation—Docetaxel—lung cancer	0.000993	0.00108	CcSEcCtD
Propericiazine—Nausea—Gemcitabine—lung cancer	0.000972	0.00106	CcSEcCtD
Propericiazine—Vomiting—Cisplatin—lung cancer	0.00097	0.00106	CcSEcCtD
Propericiazine—Vision blurred—Methotrexate—lung cancer	0.000966	0.00106	CcSEcCtD
Propericiazine—Thioridazine—CYP2E1—lung cancer	0.000964	0.0682	CrCbGaD
Propericiazine—Rash—Cisplatin—lung cancer	0.000962	0.00105	CcSEcCtD
Propericiazine—Dermatitis—Cisplatin—lung cancer	0.000961	0.00105	CcSEcCtD
Propericiazine—Diarrhoea—Etoposide—lung cancer	0.000956	0.00104	CcSEcCtD
Propericiazine—Cardiac disorder—Doxorubicin—lung cancer	0.000947	0.00103	CcSEcCtD
Propericiazine—Domperidone—ABCB1—lung cancer	0.000943	0.0667	CrCbGaD
Propericiazine—Diarrhoea—Paclitaxel—lung cancer	0.000937	0.00102	CcSEcCtD
Propericiazine—Methotrimeprazine—CYP2E1—lung cancer	0.000921	0.0651	CrCbGaD
Propericiazine—Body temperature increased—Docetaxel—lung cancer	0.000918	0.001	CcSEcCtD
Propericiazine—Arrhythmia—Doxorubicin—lung cancer	0.000911	0.000995	CcSEcCtD
Propericiazine—Nausea—Cisplatin—lung cancer	0.000906	0.00099	CcSEcCtD
Propericiazine—Vomiting—Etoposide—lung cancer	0.000888	0.00097	CcSEcCtD
Propericiazine—Rash—Etoposide—lung cancer	0.000881	0.000962	CcSEcCtD
Propericiazine—Dermatitis—Etoposide—lung cancer	0.00088	0.000961	CcSEcCtD
Propericiazine—Vomiting—Paclitaxel—lung cancer	0.000871	0.000951	CcSEcCtD
Propericiazine—Rash—Paclitaxel—lung cancer	0.000864	0.000944	CcSEcCtD
Propericiazine—Dermatitis—Paclitaxel—lung cancer	0.000863	0.000943	CcSEcCtD
Propericiazine—Hypersensitivity—Docetaxel—lung cancer	0.000855	0.000935	CcSEcCtD
Propericiazine—Confusional state—Methotrexate—lung cancer	0.000844	0.000922	CcSEcCtD
Propericiazine—Vision blurred—Doxorubicin—lung cancer	0.000837	0.000914	CcSEcCtD
Propericiazine—Infection—Methotrexate—lung cancer	0.000831	0.000908	CcSEcCtD
Propericiazine—Nausea—Etoposide—lung cancer	0.00083	0.000907	CcSEcCtD
Propericiazine—Agitation—Doxorubicin—lung cancer	0.000816	0.000891	CcSEcCtD
Propericiazine—Nausea—Paclitaxel—lung cancer	0.000814	0.000889	CcSEcCtD
Propericiazine—Hyperhidrosis—Methotrexate—lung cancer	0.000809	0.000884	CcSEcCtD
Propericiazine—Diarrhoea—Docetaxel—lung cancer	0.000794	0.000868	CcSEcCtD
Propericiazine—Hypotension—Methotrexate—lung cancer	0.000782	0.000854	CcSEcCtD
Propericiazine—Triflupromazine—ABCB1—lung cancer	0.000763	0.054	CrCbGaD
Propericiazine—Insomnia—Methotrexate—lung cancer	0.000757	0.000827	CcSEcCtD
Propericiazine—Dyspnoea—Methotrexate—lung cancer	0.000746	0.000815	CcSEcCtD
Propericiazine—Somnolence—Methotrexate—lung cancer	0.000744	0.000813	CcSEcCtD
Propericiazine—Acepromazine—ALB—lung cancer	0.00074	0.0524	CrCbGaD
Propericiazine—Dry mouth—Doxorubicin—lung cancer	0.000739	0.000808	CcSEcCtD
Propericiazine—Vomiting—Docetaxel—lung cancer	0.000738	0.000806	CcSEcCtD
Propericiazine—Rash—Docetaxel—lung cancer	0.000732	0.0008	CcSEcCtD
Propericiazine—Dermatitis—Docetaxel—lung cancer	0.000731	0.000799	CcSEcCtD
Propericiazine—Confusional state—Doxorubicin—lung cancer	0.000731	0.000798	CcSEcCtD
Propericiazine—Oedema—Doxorubicin—lung cancer	0.000725	0.000792	CcSEcCtD
Propericiazine—Thioproperazine—ALB—lung cancer	0.000723	0.0512	CrCbGaD
Propericiazine—Infection—Doxorubicin—lung cancer	0.00072	0.000786	CcSEcCtD
Propericiazine—Thiothixene—ALB—lung cancer	0.000711	0.0503	CrCbGaD
Propericiazine—Pipotiazine—ALB—lung cancer	0.000711	0.0503	CrCbGaD
Propericiazine—Tachycardia—Doxorubicin—lung cancer	0.000707	0.000773	CcSEcCtD
Propericiazine—Chlorpromazine—CYP2E1—lung cancer	0.000702	0.0497	CrCbGaD
Propericiazine—Hyperhidrosis—Doxorubicin—lung cancer	0.000701	0.000765	CcSEcCtD
Propericiazine—Nausea—Docetaxel—lung cancer	0.00069	0.000753	CcSEcCtD
Propericiazine—Hypotension—Doxorubicin—lung cancer	0.000677	0.00074	CcSEcCtD
Propericiazine—Body temperature increased—Methotrexate—lung cancer	0.000662	0.000723	CcSEcCtD
Propericiazine—Insomnia—Doxorubicin—lung cancer	0.000655	0.000716	CcSEcCtD
Propericiazine—Dyspnoea—Doxorubicin—lung cancer	0.000646	0.000706	CcSEcCtD
Propericiazine—Somnolence—Doxorubicin—lung cancer	0.000644	0.000704	CcSEcCtD
Propericiazine—Constipation—Doxorubicin—lung cancer	0.00062	0.000677	CcSEcCtD
Propericiazine—Hypersensitivity—Methotrexate—lung cancer	0.000617	0.000674	CcSEcCtD
Propericiazine—Fluphenazine—ABCB1—lung cancer	0.000587	0.0415	CrCbGaD
Propericiazine—Body temperature increased—Doxorubicin—lung cancer	0.000573	0.000626	CcSEcCtD
Propericiazine—Diarrhoea—Methotrexate—lung cancer	0.000573	0.000626	CcSEcCtD
Propericiazine—Clomipramine—ALB—lung cancer	0.000562	0.0398	CrCbGaD
Propericiazine—Clomipramine—ABCB1—lung cancer	0.000537	0.038	CrCbGaD
Propericiazine—Hypersensitivity—Doxorubicin—lung cancer	0.000534	0.000583	CcSEcCtD
Propericiazine—Vomiting—Methotrexate—lung cancer	0.000532	0.000581	CcSEcCtD
Propericiazine—Rash—Methotrexate—lung cancer	0.000528	0.000576	CcSEcCtD
Propericiazine—Dermatitis—Methotrexate—lung cancer	0.000527	0.000576	CcSEcCtD
Propericiazine—Nausea—Methotrexate—lung cancer	0.000497	0.000543	CcSEcCtD
Propericiazine—Diarrhoea—Doxorubicin—lung cancer	0.000496	0.000542	CcSEcCtD
Propericiazine—Promethazine—ABCB1—lung cancer	0.000475	0.0336	CrCbGaD
Propericiazine—Trifluoperazine—ABCB1—lung cancer	0.000469	0.0332	CrCbGaD
Propericiazine—Vomiting—Doxorubicin—lung cancer	0.000461	0.000503	CcSEcCtD
Propericiazine—Rash—Doxorubicin—lung cancer	0.000457	0.000499	CcSEcCtD
Propericiazine—Dermatitis—Doxorubicin—lung cancer	0.000456	0.000499	CcSEcCtD
Propericiazine—Quetiapine—ABCB1—lung cancer	0.000455	0.0322	CrCbGaD
Propericiazine—Nausea—Doxorubicin—lung cancer	0.00043	0.00047	CcSEcCtD
Propericiazine—Chlorpromazine—ALB—lung cancer	0.000386	0.0273	CrCbGaD
Propericiazine—Chlorpromazine—ABCB1—lung cancer	0.000368	0.026	CrCbGaD
Propericiazine—ADRA1B—GPCR downstream signaling—POMC—lung cancer	4.43e-05	0.000629	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—CYP2E1—lung cancer	4.38e-05	0.000621	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—AVP—lung cancer	4.37e-05	0.00062	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—JUNB—lung cancer	4.36e-05	0.000618	CbGpPWpGaD
Propericiazine—DRD1—GPCR downstream signaling—PIK3CB—lung cancer	4.36e-05	0.000618	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—NQO1—lung cancer	4.33e-05	0.000614	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—HSPB1—lung cancer	4.31e-05	0.000611	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—IL2—lung cancer	4.28e-05	0.000607	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—PTHLH—lung cancer	4.26e-05	0.000604	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—PIK3CG—lung cancer	4.23e-05	0.0006	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—IGF1R—lung cancer	4.2e-05	0.000596	CbGpPWpGaD
Propericiazine—DRD1—GPCR downstream signaling—CXCL8—lung cancer	4.19e-05	0.000594	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—HES1—lung cancer	4.13e-05	0.000586	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—PIK3CD—lung cancer	4.09e-05	0.000581	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—RAF1—lung cancer	4.05e-05	0.000575	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—POMC—lung cancer	4.02e-05	0.000571	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—ANXA1—lung cancer	4e-05	0.000568	CbGpPWpGaD
Propericiazine—DRD1—GPCR downstream signaling—IL2—lung cancer	4e-05	0.000568	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—PIK3CB—lung cancer	3.96e-05	0.000561	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—STK11—lung cancer	3.96e-05	0.000561	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—IL6R—lung cancer	3.93e-05	0.000557	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—STK11—lung cancer	3.9e-05	0.000554	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—FLT1—lung cancer	3.88e-05	0.00055	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—PIK3CG—lung cancer	3.84e-05	0.000545	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—EP300—lung cancer	3.84e-05	0.000545	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—FOXO3—lung cancer	3.82e-05	0.000542	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—CXCL8—lung cancer	3.8e-05	0.000539	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—APP—lung cancer	3.8e-05	0.000539	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—NOTCH3—lung cancer	3.8e-05	0.000539	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—ERBB3—lung cancer	3.78e-05	0.000536	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—FGF9—lung cancer	3.77e-05	0.000534	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—MAP2K1—lung cancer	3.74e-05	0.000531	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—SRC—lung cancer	3.73e-05	0.00053	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—PIK3CD—lung cancer	3.72e-05	0.000527	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—POMC—lung cancer	3.66e-05	0.000519	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—VEGFA—lung cancer	3.64e-05	0.000516	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—IL2—lung cancer	3.63e-05	0.000515	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—TERT—lung cancer	3.62e-05	0.000513	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—GSTP1—lung cancer	3.61e-05	0.000512	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—JUNB—lung cancer	3.6e-05	0.00051	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—NRAS—lung cancer	3.59e-05	0.000509	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—AVP—lung cancer	3.58e-05	0.000507	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—PIK3CB—lung cancer	3.57e-05	0.000506	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—CAT—lung cancer	3.52e-05	0.000499	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—FGFR1—lung cancer	3.51e-05	0.000499	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—PIK3CG—lung cancer	3.49e-05	0.000495	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—HIF1A—lung cancer	3.46e-05	0.000491	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—IGF1R—lung cancer	3.44e-05	0.000488	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—MAPK3—lung cancer	3.44e-05	0.000488	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—CXCL8—lung cancer	3.43e-05	0.000486	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—ABCB1—lung cancer	3.42e-05	0.000485	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—HES1—lung cancer	3.38e-05	0.00048	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—PIK3CD—lung cancer	3.38e-05	0.000479	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—TYMS—lung cancer	3.36e-05	0.000476	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—APOA1—lung cancer	3.34e-05	0.000474	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—POMC—lung cancer	3.32e-05	0.000471	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—GSTM1—lung cancer	3.32e-05	0.000471	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—RAF1—lung cancer	3.32e-05	0.000471	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—KDR—lung cancer	3.31e-05	0.00047	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—IL2—lung cancer	3.28e-05	0.000465	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—STK11—lung cancer	3.26e-05	0.000463	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—IL6R—lung cancer	3.24e-05	0.00046	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—PIK3CB—lung cancer	3.24e-05	0.00046	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—FOXO3—lung cancer	3.15e-05	0.000447	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—CYP1A1—lung cancer	3.15e-05	0.000446	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—ERCC2—lung cancer	3.12e-05	0.000443	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—CXCL8—lung cancer	3.11e-05	0.000442	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—ERBB3—lung cancer	3.09e-05	0.000439	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—KRAS—lung cancer	3.09e-05	0.000439	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—MAP2K1—lung cancer	3.09e-05	0.000438	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—PIK3CD—lung cancer	3.07e-05	0.000435	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—PIK3CG—lung cancer	3.05e-05	0.000433	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—APC—lung cancer	3.05e-05	0.000433	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—KIT—lung cancer	3.05e-05	0.000433	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—NRAS—lung cancer	3.05e-05	0.000433	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—EGF—lung cancer	3.01e-05	0.000428	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—IL2—lung cancer	2.98e-05	0.000422	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—TERT—lung cancer	2.96e-05	0.00042	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—AVP—lung cancer	2.95e-05	0.000419	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—PIK3CB—lung cancer	2.94e-05	0.000418	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—MAPK3—lung cancer	2.92e-05	0.000414	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—POMC—lung cancer	2.9e-05	0.000412	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—FGFR1—lung cancer	2.88e-05	0.000408	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—BRAF—lung cancer	2.87e-05	0.000407	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—IGF1R—lung cancer	2.84e-05	0.000403	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—PIK3CA—lung cancer	2.84e-05	0.000403	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—HIF1A—lung cancer	2.83e-05	0.000402	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—IL6R—lung cancer	2.83e-05	0.000402	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—CXCL8—lung cancer	2.83e-05	0.000401	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—CREBBP—lung cancer	2.83e-05	0.000401	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—HES1—lung cancer	2.79e-05	0.000396	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—EGFR—lung cancer	2.78e-05	0.000394	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—TP53—lung cancer	2.75e-05	0.00039	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—RAF1—lung cancer	2.74e-05	0.000388	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—APOA1—lung cancer	2.74e-05	0.000388	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—KDR—lung cancer	2.71e-05	0.000385	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—IL2—lung cancer	2.7e-05	0.000384	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—APOA1—lung cancer	2.7e-05	0.000383	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—MAP2K1—lung cancer	2.7e-05	0.000383	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—PIK3CD—lung cancer	2.68e-05	0.00038	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—PIK3CB—lung cancer	2.67e-05	0.000379	CbGpPWpGaD
Propericiazine—DRD1—GPCR downstream signaling—PIK3CA—lung cancer	2.66e-05	0.000377	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—HRAS—lung cancer	2.63e-05	0.000373	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—KRAS—lung cancer	2.62e-05	0.000372	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—CXCL8—lung cancer	2.57e-05	0.000364	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—ERBB3—lung cancer	2.55e-05	0.000362	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—PIK3CG—lung cancer	2.5e-05	0.000354	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—APC—lung cancer	2.5e-05	0.000354	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—KIT—lung cancer	2.5e-05	0.000354	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—NRAS—lung cancer	2.5e-05	0.000354	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—EGF—lung cancer	2.47e-05	0.00035	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—PIK3CG—lung cancer	2.46e-05	0.00035	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—IL2—lung cancer	2.46e-05	0.000348	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—TERT—lung cancer	2.45e-05	0.000347	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—PIK3CA—lung cancer	2.41e-05	0.000342	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—MDM2—lung cancer	2.4e-05	0.000341	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—RAF1—lung cancer	2.39e-05	0.00034	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—MAPK3—lung cancer	2.39e-05	0.000339	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—POMC—lung cancer	2.38e-05	0.000337	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—FGFR1—lung cancer	2.38e-05	0.000337	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—ERBB2—lung cancer	2.37e-05	0.000336	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—BRAF—lung cancer	2.35e-05	0.000333	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—POMC—lung cancer	2.35e-05	0.000333	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—HIF1A—lung cancer	2.34e-05	0.000332	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—MTOR—lung cancer	2.34e-05	0.000331	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—PIK3CB—lung cancer	2.34e-05	0.000331	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—AKT1—lung cancer	2.32e-05	0.000329	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—IL6R—lung cancer	2.32e-05	0.000329	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—CREBBP—lung cancer	2.32e-05	0.000328	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—CREBBP—lung cancer	2.29e-05	0.000324	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—EGFR—lung cancer	2.28e-05	0.000323	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—APOA1—lung cancer	2.26e-05	0.00032	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—CXCL8—lung cancer	2.25e-05	0.000319	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—KDR—lung cancer	2.24e-05	0.000317	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—HRAS—lung cancer	2.23e-05	0.000316	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—MAP2K1—lung cancer	2.21e-05	0.000314	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—PIK3CD—lung cancer	2.2e-05	0.000311	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—PIK3CA—lung cancer	2.17e-05	0.000308	CbGpPWpGaD
Propericiazine—DRD1—GPCR downstream signaling—AKT1—lung cancer	2.17e-05	0.000308	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—PIK3CD—lung cancer	2.17e-05	0.000307	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—KRAS—lung cancer	2.15e-05	0.000305	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—CASP3—lung cancer	2.15e-05	0.000305	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—IL2—lung cancer	2.15e-05	0.000304	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—ALB—lung cancer	2.14e-05	0.000303	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—IL6—lung cancer	2.14e-05	0.000303	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—CCND1—lung cancer	2.09e-05	0.000297	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—JUN—lung cancer	2.09e-05	0.000296	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—PIK3CG—lung cancer	2.06e-05	0.000292	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—APC—lung cancer	2.06e-05	0.000292	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—KIT—lung cancer	2.06e-05	0.000292	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—NRAS—lung cancer	2.06e-05	0.000292	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—EGF—lung cancer	2.04e-05	0.000289	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—MMP9—lung cancer	2.03e-05	0.000288	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—CDKN1A—lung cancer	2.02e-05	0.000287	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—PTEN—lung cancer	2.02e-05	0.000286	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—PIK3CA—lung cancer	1.97e-05	0.00028	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—MAPK3—lung cancer	1.97e-05	0.00028	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—AKT1—lung cancer	1.97e-05	0.000279	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—MDM2—lung cancer	1.97e-05	0.000279	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—POMC—lung cancer	1.96e-05	0.000278	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—RAF1—lung cancer	1.96e-05	0.000278	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—ERBB2—lung cancer	1.94e-05	0.000275	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—BRAF—lung cancer	1.94e-05	0.000275	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—EP300—lung cancer	1.93e-05	0.000273	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—IL6R—lung cancer	1.91e-05	0.000272	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—MTOR—lung cancer	1.91e-05	0.000271	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—PIK3CB—lung cancer	1.91e-05	0.000271	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CREBBP—lung cancer	1.91e-05	0.000271	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—PIK3CB—lung cancer	1.89e-05	0.000268	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—EGFR—lung cancer	1.88e-05	0.000266	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—SRC—lung cancer	1.87e-05	0.000266	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—PTGS2—lung cancer	1.87e-05	0.000265	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—CXCL8—lung cancer	1.84e-05	0.000261	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—HRAS—lung cancer	1.83e-05	0.000259	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—MAP2K1—lung cancer	1.82e-05	0.000259	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—VEGFA—lung cancer	1.82e-05	0.000259	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—PIK3CD—lung cancer	1.81e-05	0.000257	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—STAT3—lung cancer	1.81e-05	0.000256	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—NRAS—lung cancer	1.8e-05	0.000256	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—PIK3CA—lung cancer	1.79e-05	0.000255	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—AKT1—lung cancer	1.78e-05	0.000252	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—KRAS—lung cancer	1.77e-05	0.000252	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—CASP3—lung cancer	1.76e-05	0.00025	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—IL2—lung cancer	1.76e-05	0.000249	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—IL6—lung cancer	1.75e-05	0.000248	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—MAPK3—lung cancer	1.73e-05	0.000245	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—CCND1—lung cancer	1.71e-05	0.000243	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—JUN—lung cancer	1.71e-05	0.000243	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—MYC—lung cancer	1.68e-05	0.000238	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—MMP9—lung cancer	1.66e-05	0.000236	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—CDKN1A—lung cancer	1.66e-05	0.000235	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—PTEN—lung cancer	1.65e-05	0.000235	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—EGFR—lung cancer	1.64e-05	0.000233	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—PTEN—lung cancer	1.63e-05	0.000232	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—PIK3CA—lung cancer	1.63e-05	0.000231	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—MDM2—lung cancer	1.62e-05	0.00023	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—RAF1—lung cancer	1.62e-05	0.000229	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—AKT1—lung cancer	1.61e-05	0.000229	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—ERBB2—lung cancer	1.6e-05	0.000227	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—PIK3CB—lung cancer	1.58e-05	0.000224	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—MTOR—lung cancer	1.58e-05	0.000224	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—EP300—lung cancer	1.58e-05	0.000224	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—EP300—lung cancer	1.56e-05	0.000221	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—KRAS—lung cancer	1.55e-05	0.00022	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—SRC—lung cancer	1.53e-05	0.000218	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CXCL8—lung cancer	1.52e-05	0.000215	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—HRAS—lung cancer	1.51e-05	0.000214	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—VEGFA—lung cancer	1.49e-05	0.000212	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—STAT3—lung cancer	1.48e-05	0.00021	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—NRAS—lung cancer	1.48e-05	0.000209	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—AKT1—lung cancer	1.47e-05	0.000208	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CASP3—lung cancer	1.45e-05	0.000206	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—IL2—lung cancer	1.45e-05	0.000206	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—IL6—lung cancer	1.44e-05	0.000205	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—PIK3CA—lung cancer	1.42e-05	0.000202	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CCND1—lung cancer	1.41e-05	0.000201	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—MAPK3—lung cancer	1.41e-05	0.0002	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—JUN—lung cancer	1.41e-05	0.0002	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—TP53—lung cancer	1.38e-05	0.000195	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—MYC—lung cancer	1.37e-05	0.000195	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—MMP9—lung cancer	1.37e-05	0.000195	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CDKN1A—lung cancer	1.37e-05	0.000194	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—PTEN—lung cancer	1.36e-05	0.000194	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—EGFR—lung cancer	1.34e-05	0.000191	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—AKT1—lung cancer	1.33e-05	0.000189	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—HRAS—lung cancer	1.32e-05	0.000187	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—EP300—lung cancer	1.3e-05	0.000185	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—KRAS—lung cancer	1.27e-05	0.00018	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—SRC—lung cancer	1.27e-05	0.00018	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—IL6—lung cancer	1.26e-05	0.000179	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—VEGFA—lung cancer	1.23e-05	0.000175	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—STAT3—lung cancer	1.22e-05	0.000173	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—NRAS—lung cancer	1.22e-05	0.000173	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—PIK3CA—lung cancer	1.17e-05	0.000165	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—MAPK3—lung cancer	1.17e-05	0.000165	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—AKT1—lung cancer	1.16e-05	0.000165	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—PIK3CA—lung cancer	1.15e-05	0.000163	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—MYC—lung cancer	1.13e-05	0.000161	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—TP53—lung cancer	1.13e-05	0.00016	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—EGFR—lung cancer	1.11e-05	0.000157	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—HRAS—lung cancer	1.08e-05	0.000153	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—KRAS—lung cancer	1.05e-05	0.000149	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—IL6—lung cancer	1.03e-05	0.000147	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—PIK3CA—lung cancer	9.63e-06	0.000137	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—AKT1—lung cancer	9.53e-06	0.000135	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—AKT1—lung cancer	9.41e-06	0.000133	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—TP53—lung cancer	9.31e-06	0.000132	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—HRAS—lung cancer	8.91e-06	0.000126	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—IL6—lung cancer	8.53e-06	0.000121	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—AKT1—lung cancer	7.87e-06	0.000112	CbGpPWpGaD
